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Abstract Patients with chronic heart failure (CHF) have
a signiﬁcantly lower peak aerobic capacity compared to
healthy subjects, and, may therefore experience more
inconvenience during the performance of domestic activi-
ties of daily life (ADLs). To date, the extent to which
task-related oxygen uptake, heart rate, ventilation and symp-
toms during the performance of ADLs in CHF patients is
different than in healthy subjects remains uncertain. Gen-
eral demographics, pulmonary function, body composition
and peak aerobic capacity were assessed in 23 CHF out-
patients and 20 healthy peers. In addition, the metabolic
requirement of ﬁve simple self-paced domestic ADLs was
assessed using a mobile oxycon. Task-related oxygen
uptake (ml/min) was similar or lower in CHF patients
compared to healthy subjects. In contrast, patients with
CHF performing ADLs consumed oxygen at a higher
proportion of their peak aerobic capacity than healthy
subjects (p\0.05). For example, getting dressed resulted
in a mean task-related oxygen uptake of 49% of peak
aerobic capacity, while sweeping the ﬂoor resulted in a
mean task-related oxygen uptake of 52% of peak aerobic
capacity, accompanied by signiﬁcantly higher Borg
symptom scores for dyspnea and fatigue (p\0.05).
Patients with CHF experience use a higher proportion of
their peak aerobic capacity, peak ventilation and peak heart
rate during the performance of simple self-paced domestic
ADL than their healthy peers. These ﬁndings represent a
necessary step in improving our understanding of
improving what troubles patients the most—not being able
to do the things that they could when they were healthy.
Keywords Self-paced  ADL  Domestic  Chronic heart
failure
Introduction
Oxygen uptake increases during the performance of simple
activities of daily life (ADLs) and, in turn, laying claim to
the aerobic capacity of individuals (Ainsworth et al. 2000;
Velloso et al. 2003). Patients with chronic heart failure
(CHF) have a signiﬁcantly lower peak aerobic capacity
compared to age-matched healthy subjects (Gosker et al.
2003). Patients with CHF may therefore experience more
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domestic ADLs. In fact, a reduced peak aerobic capacity
has been shown to contribute to a reduced ability to per-
form habitual ADLs in CHF (Gosker et al. 2003; Mezzani
et al. 2000; van den Berg-Emons et al. 2005).
Patients with chronic obstructive pulmonary disease
(COPD) use a higher proportion of their peak oxygen
consumption during the performance of simple domestic
ADLs (Velloso and Jardim 2006; Velloso et al. 2003).
Based on the striking similarities in systemic factors con-
tributing to exercise intolerance in patients with COPD and
CHF (Gosker et al. 2003), the present authors reasoned that
patients with CHF may also use a higher proportion of their
peak aerobic capacity during the performance of simple
domestic ADLs compared to healthy elderly subjects.
To date, actual assessment of task-related oxygen
uptake, heart rate and ventilation during the performance of
domestic ADLs in patients with CHF has not been per-
formed. So, whether task-related oxygen uptake during the
performance of ADLs in patients with CHF is different
than in healthy subjects remains uncertain. Nevertheless, a
better insight in the task-related metabolic requirement of
simple domestic ADLs in patients with CHF may allow
clinicians to better develop patient management method-
ologies to reduce daily symptoms and to improve the
performance of problematic ADLs in these patients.
We aimed to study task-related oxygen uptake, heart
rate, minute ventilation and symptoms of dyspnoea and
fatigue during the performance of ﬁve self-paced domestic
ADLs in patients with CHF and healthy subjects. A priori,
we hypothesized that patients with CHF have a relatively
higher task-related oxygen uptake, heart rate and minute
ventilation during domestic ADLs than healthy elderly
subjects, accompanied by higher symptoms perception.
Methods
Population
Patients and healthy subjects (45–80 years of age) were
recruitedbetweenJuly2008andFebruary2009.Twenty-three
clinically stable CHF outpatients and 20 healthy peers vol-
unteered to participate in the present study, which was
approved by the institutional review board of the Maastricht
University Medical Centre (MEC08-3-032). All tests were
performed at the CIRO? and were in accordance with the
World Medical Association declaration of Helsinki (2004).
Patients were recruited at the outpatient clinic of
CIRO?, a centre of expertise for chronic organ failure
(Horn, the Netherlands). Patients had to be diagnosed with
CHF and had the willingness to participate. Exclusion
criteria were any unstable medical conditions that were
contraindicative to exercise testing (e.g., hospitalization or
unstable angina\4 weeks of enrolment or acute myocardial
infarction \6 months of enrolment), neurological diseases,
locomotor disorders and/or the use of long-term oxygen
therapy.Healthysubjects[e.g.,nocurrent(drug)treatmentby
a medical specialist] were recruited by posters and amongst
healthy subjects who participated in previous trials. At
enrolment, written informed consent was obtained from
potential participants, and study eligibility was determined.
Clinical phenotyping
General demographics, pulmonary function, body compo-
sition and peak aerobic capacity were assessed in all par-
ticipants. Standard spirometry was obtained by a mass
ﬂowmeter (Masterscreen PFT, Carefusion Netherlands,
Houten, the Netherlands) with numerical integration of the
ﬂow signal to determine forced expiratory volume and
forced vital capacity (Miller et al. 2005; Spruit et al. 2007).
A symptom-limited cardiopulmonary exercise test on a
bicycle was used to determine peak aerobic capacity and
was performed according to international guidelines
(American Thoracic Society; American College of Chest
Physicians 2003). In brief, after calibration of the oxygen
and carbon dioxide analyzer and ﬂow mass sensor, the
participants were asked to sit on an microprocessor con-
trolled eddy current brake cycle ergometer (Ergoline type
Ergoselect 200P, Carefusion Netherlands, Houten, the
Netherlands). This stationary bicycle can handle cycling
loads up to 400 Watts independent of the number of rev-
olutions per minute. The saddle was mechanically adjusted
properly to avoid the maximal extension of the knee. After
a 3-min rest period sitting on the ergometer, exercise began
with a 3-min warmup period at 0 Watts, followed by a
progressively increasing ramp protocol of 10–15 Watts/
min (CHF patients) or 15–25 Watts/min (healthy age-
matched subjects), based on anthropometric data and
functional impairment degree of the patients, to perform
for an exercise time lasting 8–12 min. All patients had to
maintain a pedaling frequency of 60–65 revolutions
per minute, indicated by a digital display placed on the
monitor of the ergometer. Breath-by-breath oxygen uptake
(ml/min), carbon dioxide production (ml/min) and minute
ventilation (l) were collected during the test (Oxycon Pro,
Carefusion Netherlands, Houten, the Netherlands). Partic-
ipants were continuously monitored by a 12-lead electro-
cardiogram (Corina; GE Medical Systems IT, Milwaukee,
WI, USA) and a pulse oximeter (Model 9600; Nonin
Medical Inc, Minneapolis, MN, USA). Blood pressure was
measured at 2-min intervals. Peak aerobic capacity was
recorded as the mean value of oxygen uptake during the
last 30 s of the test and expressed as absolute value in
ml/min.
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son comorbidity index, which is a weighted index that
takes into account the number and seriousness of co-mor-
bid diseases (Charlson et al. 1987).
Patients with CHF were on various cardiac drug ther-
apies: ACE-inhibitors or angiotensin receptor blockers
(96%); b-blockers (92%); diuretics (92%); anticoagulant
therapy (warfarin, 57%; aspirin, 43%); statins (57%) and/
or isosobide mononitrate (26%). Moreover, some patients
also received non-cardiac drug treatment: drugs to treat
gastroesophageal reﬂux disease (22%); drugs to treat
diabetes mellitus type II (22%); a benzodiazepine (9%);
a drug prescribed for the pain of gouty arthritis (13%);
and/or pulmonary inhalation drugs (13%). None of the
healthy age-matched subjects used physician-prescribed
drugs.
Activities of daily life
The metabolic requirement of 5 simple self-paced domestic
ADLs was assessed using a mobile oxycon (Oxycon
Mobile, CareFusion, San Diego, CA, USA) which provides
reliable measurements of oxygen uptake and ventilation
(Diaz et al. 2008). A mobile oxycon has been used before
in patients with COPD without adverse events (Sillen et al.
2008; Sillen et al. 2010). Indeed, participants are able to
move freely without discomfort.
Online breath-by-breath calculations of oxygen uptake
and ventilation were recorded by the portable metabolic
system during the performance of ﬁve domestic ADLs in
the kitchen of the Department of Occupational Therapy of
CIRO?: putting on two socks (sitting in a chair), two shoes
(sitting in a chair) and a vest (standing, ADL1); folding
eight towels (standing, ADL2); putting away groceries (i.e.
6 cans of beans of 400 g each) in the cupboard (standing
and walking, ADL3); washing up 4 dishes, 4 cups and 4
saucers (standing, ADL4); and sweeping the ﬂoor for
4 min (standing and walking, ADL5). All ADLs were
preceded with 4-min resting intervals (sitting in a chair).
All participants were asked to perform the ADLs at their
own pace as the participants accomplish them in their real
life; and to score the degree of dyspnoea and fatigue at the
beginning and end of all ADLs using a modiﬁed
Borg symptom score ranging from 0 (no symptoms) to 10
points (worst symptoms ever experienced). Heart rate was
monitored using a Polar belt (Polar Electro, Kempele,
Finland).
Oxygen uptake during ADLs expressed as a proportion
of the pre-determined peak aerobic capacity was chosen as
primary outcome. Task-related oxygen uptake (ml/min and
ml/kg/min); task-related heart rate and ventilation (both
expressed as proportion of the peak heart rate and venti-
lation, respectively); the time to accomplish the ﬁrst 4
ADLs (ADL5 was always 4 min); and Borg symptom
scores for dyspnoea and fatigue at the end of each ADL
were chosen as secondary outcomes.
Statistics
Data are presented as mean ± standard error of the mean
or as prevalence (%), as appropriate. Unpaired Student’s
t test was used to determine differences between patients
with CHF and healthy peers. A posteriori, an unpaired
Student’s t-test was used to determine differences in task-
related oxygen uptake between CHF patients without
COPD (n = 19) and healthy peers. All data analyses were
performed using GraphPad/Prism version 5 software and
SPSS 15.0. Based on data from a previous manuscript on
task-related oxygen uptake in patients with COPD (Velloso
et al. 2003) a sample size was estimated. Indeed, to have a
90% chance of detecting a 15% difference in task-related
oxygen uptake at an a level of 0.05, the power calculation
indicates that each of the two groups needed to enrol at
least 20 subjects. A priori, the level of signiﬁcance was set
at B0.05. No adjustment was made to the statistical sig-
niﬁcance level for multiple comparisons.
Results
Characteristics
Patients had symptoms compatible with New York Heart
Association (NYHA) functional class I, II or III (n = 2, 15
and 6, respectively). CHF was of a non-ischemic aetiology
in 14 patients (61%). Seven patients (30%) had an
implantable cardioverter deﬁbrillator and three patients had
a cardiac pacemaker (13%). Twelve patients (52%) had
mitral regurgitation, in combination with aortic regurgita-
tion (n = 2), tricuspid regurgitation (n = 1) or a combi-
nation thereof (n = 1). Moreover, 13 patients (57%) had a
score of C2 points on the Charlson co-morbidity index:
myocardial infarction (n = 7); peripheral artery disease
(n = 3); COPD (n = 4); moderate renal failure (n = 1);
and/or diabetes mellitus II (n = 5). All healthy age-mat-
ched subjects scored 0 points on the Charlson co-morbidity
index. Consequently, CHF patients had a signiﬁcantly
higher score on the Charlson co-morbidity index
(p\0.01).
Although the proportion of men, and the average age,
body weight and body mass index were comparable
between groups, patients with CHF had signiﬁcantly worse
resting pulmonary function and lower peak aerobic
capacity during the CPET than healthy peers (Table 1).
Moreover, CHF patients had a signiﬁcantly lower peak
heart rate, while peak ventilation (expressed as a proportion
Eur J Appl Physiol (2011) 111:1679–1686 1681
123of the calculated maximal voluntary ventilation), Borg
dyspnoea scores and Borg fatigue scores at the end of
CPET were comparable (Table 1).
Domestic ADLs
All participants were able to complete the study protocol.
However, patients with CHF needed more time to complete
ADL1, ADL2 and ADL4 than healthy age-matched subjects:
94.6 ± 5.0 versus 62.8 ± 3.0 s; 149.2 ± 6.3 versus
115.4 ± 4.6 s and 117.1 ± 6.5 versus 72.3 ± 4.4 s, respec-
tively (all p\0.001). The time needed to complete ADL3
was comparable (65.6 ± 4.0 vs. 62.8 ± 3.7 s, p = 0.61).
Task-related metabolic requirements
Task-related oxygen uptake (ml/min) was similar between
patients with CHF and healthy age-matched subjects for
ADL1 [mean difference (95%CI): -11 ml/min (-110, 87),
p = 0.82], ADL4 [-52 ml/min (-121, 17), p = 0.14] and
ADL5 [-35 ml/min (-133, 64), p = 0.4831]; and lower
for ADL2 [-105 ml/min (-182, -27), p = 0.01] and
ADL3 [-101ml/min (-191, -10), p = 0.03] in patients
with CHF (Fig. 1a).
Patients with CHF performed ADLs 1, 2, 4 and 5 at a
higher proportion of their peak oxygen uptake than healthy
peers: ADL1 [13.4% (5.7, 21.1), p = 0.0011]; ADL2
[7.6% (0.0, 15.1), p = 0.05]; ADL4 [9.2% (2.4, 15.9),
p = 0.01]; and ADL5 [13.8% (5.1, 22.6), p = 0.003],
while task-related oxygen uptake for ADL3 tended to
be higher [7.4% (-0.2, 14.9), p = 0.055, Fig. 1b]. In
accordance, the task-related heart rate and ventilation
were signiﬁcantly higher for all time points (p\0.01,
Figs. 2, 3).
Differences in task-related oxygen uptake (expressed as
proportion of the peak aerobic capacity) between CHF
patients and the healthy subjects remained after exclusion
of 4 CHF patients with COPD: ADL1 [13.6% (5.5, 21.6),
p = 0.0016]; ADL4 [9.2% (2.2, 16.1), p = 0.0115]; and
ADL5 [14.6% (5.2, 24.0), p = 0.0033]. Task-related oxy-
gen uptake for ADL2 [7.5% (-0.4, 15.4), p = 0.06] and
ADL3 [7.2% (-0.6, 15.0), p = 0.07] tended to be higher in
the CHF patients without COPD compared to healthy age-
matched subjects.
Borg symptom scores
Even though Borg symptom scores for dyspnoea and fati-
gue at the end of all ADLs were signiﬁcantly higher in
patients with CHF compared to healthy peers (p\0.01),
patients’ task-related symptom scores were quite low
(Table 2).
Table 1 Demographic, lung
function characteristics and
exercise capacity of CHF
patients and age-matched
healthy subjects
Results are presented as
mean ± standard error of the
mean. FEV1, forced expiratory
volume in the ﬁrst second; FVC,
forced vital capacity; l, litre; kg,
kilogram; kg/m
2, kilogram per
square meter; ml/min, millilitre
per minute; % MVV, percentage
of calculated maximal voluntary
ventilation (409 FEV1 in litres);
bpm, beats per minute; % max
HR, percentage of calculated
heart rate (220—age in years);
VE, ventilation
CHF (n = 23) Healthy (n = 20) p-Value
Demographics
Men/women (n) 16/7 12/8 –
Age (years) 59.5 ± 2.6 62.1 ± 1.2 0.40
Cardiac and pulmonary function
LVEF (%) 36 ± 2– –
NYHA class I/II/III/IV (n) 2/15/6/0 – –
FEV1 (l) 2.6 ± 0.2 3.4 ± 0.1 0.0020
FEV1 (% predicted) 84 ± 3.0 119 ± 5.4 0.0001
FEV1/FVC (%) 70 ± 2.4 77 ± 1.0 0.0165
Body composition
Body weight (kg) 82 ± 37 9 ± 3 0.56
Body mass index (kg/m
2)2 7 ± 12 7 ± 1 0.89
Cardiopulmonary exercise test
Peak power output (Watts) 108 ± 9 212 ± 13 0.0016
Peak VO2 (ml/min) 1,475 ± 104 2,155 ± 172 0.0012
Peak VO2 (ml/kg/min) 18.1 ± 1.1 27.5 ± 2.3 0.0004
Peak VE (l) 60 ± 48 7 ± 6 0.0005
Peak VE (% MVV) 60 ± 36 5 ± 4 0.31
Peak HR (bpm) 123 ± 5 155 ± 4 0.0001
Peak HR (% max HR) 77 ± 29 8 ± 2 0.0001
Borg score dyspnoea (points) 4.5 ± 0.4 5.5 ± 0.5 0.12
Borg score fatigue (points) 5.3 ± 0.5 5.7 ± 0.5 0.54
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The present study is the ﬁrst to report detailed information
about the metabolic requirement of ﬁve simple self-paced
domestic ADLs in patients with CHF. Despite optimal
cardiac drug treatment, patients with CHF performing
simple self-paced domestic ADLs consumed oxygen at a
higher proportion to their peak oxygen uptake than healthy
elderly subjects. Moreover, patients with CHF had signif-
icantly higher Borg symptom scores for dyspnoea and
fatigue after each domestic ADL.
Metabolic requirement of simple domestic ADLs
Even though the task-related oxygen uptake (ml/min and
ml/kg/min) was similar or even a little bit lower in patients
with CHF compared to healthy age-matched subjects, the
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Fig. 1 Oxygen uptake during domestic activities of daily life in
patients with CHF and healthy subjects. a Mean ± SEM task-related
oxygen uptake (VO2, ml/min) during the performance of ﬁve
domestic activities of daily life (ADLs) in patients with chronic heart
failure (n = 23, grey bars) and healthy subjects (n = 20, black bars).
*p\0.05 versus healthy subjects. b Mean ± SEM task-related
oxygen uptake (VO2, proportion of the peak oxygen uptake measured
during CPET, % peak VO2) during the performance of ﬁve domestic
activities of daily life (ADL 1–5) in patients with chronic heart failure
(n = 23, grey bars) and healthy subjects (n = 20, black bars).
*p\0.05 versus healthy subjects
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Fig. 2 Heart rate duringdomesticactivitiesofdaily lifein patientswith
CHF and healthy subjects. Mean ± SEM task-related heart rate (HR,
percent peak heart rate measured during CPET, % peak HR) during the
performanceofﬁvedomesticactivitiesofdailylife(ADL1–5)inpatients
with chronic heart failure (n = 23, grey bars) and healthy subjects
(n = 20, black bars). *p\0.05 versus healthy subjects
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Fig. 3 Ventilation during domestic activities of daily life in patients
with CHF and healthy subjects. Mean ± SEM task-related ventilation
(VE, percent peak ventilation measured during CPET, % peak VE)
during the performance of ﬁve domestic activities of daily life (ADL
1–5) in patients with chronic heart failure (n = 23, grey bars) and
healthy subjects (n = 20, black bars). *p\0.05 versus healthy
subjects
Table 2 Task-related Borg symptom scores for CHF patients and
age-matched healthy subjects
CHF (n = 23) Healthy (n = 20) p-Value
Borg dyspnea scores (points)
ADL1 0.9 ± 0.2 (range 0–4) 0.0 ± 0.0 (range 0–0) 0.001
ADL2 1.0 ± 0.2 (range 0–4) 0.0 ± 0.0 (range 0–0.5) 0.001
ADL3 1.2 ± 0.3 (range 0–5) 0.0 ± 0.0 (range 0–0) 0.001
ADL4 1.1 ± 0.3 (range: 0–5) 0.0 ± 0.0 (range 0–0) 0.001
ADL5 2.0 ± 0.3 (range 0–5) 0.1 ± 0.1 (range 0–1) 0.001
Borg fatigue scores (points)
ADL1 0.5 ± 0.2 (range 0–3) 0.0 ± 0.0 (range 0–0.5) 0.019
ADL2 0.5 ± 0.2 (range 0–3) 0.0 ± 0.0 (range 0–0) 0.017
ADL3 0.5 ± 0.2 (range 0–3) 0.0 ± 0.0 (range 0–0) 0.012
ADL4 0.7 ± 0.2 (range 0–4) 0.0 ± 0.0 (range 0–0) 0.008
ADL5 1.1 ± 0.3 (range 0–3) 0.1 ± 0.1 (range 0–1) 0.001
Results are presented as mean ± standard error of the mean (range)
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123relative metabolic requirement was clearly higher in
patients. Indeed, a signiﬁcantly lower peak oxygen uptake
obtained during CPET in patients with CHF is most
probably the main reason for this ﬁnding.
So, the performance of ﬁve simple domestic ADLs is
laying a relatively moderate-to-high claim to the impaired
peak aerobic capacity of patients with CHF (Fig. 1b). To
our surprise, putting on two socks, two shoes and a vest
resulted in a mean task-related oxygen uptake of 49% of
the peak oxygen uptake obtained during CPET, while
sweeping the ﬂoor for 4 min resulted in a mean task-related
oxygen uptake of 52% of the peak oxygen uptake obtained
during CPET. Indeed, many physical exercise training
programs in CHF are initially performed at a training
intensity of 50–60% of peak oxygen uptake obtained dur-
ing CPET (Barnard et al. 2000; Delagardelle et al. 2002;
Feiereisen et al. 2007). These ﬁndings may, at least in part,
explain the daily experience of symptoms of dyspnoea and
fatigue that patients with CHF frequently report (Raphael
et al. 2007). Indeed, the relative requirement on the
impaired cardiopulmonary system is clearly higher than in
healthy peers (Figs. 1b, 2, 3).
Interestingly, patients with COPD also used about 50%
of the peak aerobic capacity during sweeping the ﬂoor for
5 min (Velloso et al. 2003). So, patients with chronic
organ failure seem to have comparable metabolic
requirements to execute simple domestic ADLs, irre-
spective of the type of primary organ failure. This may
not come as a complete surprise. Indeed, similarities
between patients with CHF or COPD were reported for
body composition, muscle strength and endurance of the
upper and lower limbs, self-reported physical activity
levels and peak aerobic capacity (Franssen et al. 2002;
Gosker et al. 2003).
The extent to which improvements in peak aerobic
capacity following an exercise-based CHF rehabilitation
program (Rees et al. 2004) may improve the performance
of domestic ADLs and decrease symptom scores in patients
with CHF remains uncertain and warrants additional
research. Indeed, it seems reasonable to postulate that an
improved peak aerobic capacity can at least in part reduce
the relatively high metabolic requirement on the impaired
cardiopulmonary system in CHF.
Methodological considerations
The external validity of the present ﬁndings is limited to
CHF patients with NYHA II and III. Thus, the present data
should not be uncritically applied to NYHA I and IV
patient subsets. Moreover, the authors a priori choose to
assess the metabolic requirement of ﬁve simple domestic
ADLs, speciﬁcally excluding relevant daily physical
activities like walking. In fact, the relatively high
metabolic requirement of walking has already been studied
in CHF (Kervio et al. 2004).
The extent to which task-related oxygen uptake will
change by altering the order of the tested ﬁve domestic
ADLs remains uncertain. Surprisingly, Borg symptom
scores for dyspnea and fatigue were rather low after each
domestic ADL, which suggests that the tested ADLs were
not ADLs that the patients found particularly troublesome.
These results suggest that patients with CHF may adjust
their activity level such that with a relatively higher strain
they reach rather low symptom scores. In addition, it may
also be an indication that any individual ADL task in iso-
lation does not create symptoms. It will therefore be
important in future studies to assess the speciﬁc ADL tasks
which patients ﬁnd particularly troubling as well as the
effects of a combination of tasks in various orders of
succession. Certainly, this may be challenging, as the
variability in ADL tasks that individuals ﬁnd troubling is
likely to be wide (Raphael et al. 2007). Nonetheless, such
detailed examination of the effects of ADLs will poten-
tially lead to a better understanding of what makes ADL
tasks troubling in CHF and the further development of
known interventional strategies, like comprehensive
patient-tailored rehabilitation programs. For daily clinical
routine, validated questionnaires and/or semi-structured
interviews are suitable to identify problematic ADLs in
patients with CHF (Raphael et al. 2007; Sewell and Singh
2001).
Unfortunately, the degree of task-related hyperventila-
tion (reﬂected by the slope of increase of ventilation rela-
tive to carbon dioxide production) remains unknown. In
fact, the portable system used to assess task-related meta-
bolic requirements provides reliable measurement of task-
related oxygen uptake and ventilation, but is less reliable
for measuring carbon dioxide production (Diaz et al. 2008).
Moreover, the ventilatory threshold has been widely
applied in patients with CHF. Nevertheless, signiﬁcant
error in interpreting the ventilatory threshold in CHF
patients will occur even with experienced reviewers
(Myers et al. 2010). Therefore, future studies may want to
consider the assessment of (arterial) lactate to determine
inadequate oxygen supply to the mitochondria during
simple ADLs (Wasserman et al. 1990).
The increased physiologic strain in patients with CHF
may be due to the presence of COPD (Dickstein et al.
2008; Norberg et al. 2008). Indeed, 17% of the current
CHF patients have COPD, which is in line with previous
studies (Le Jemtel et al. 2007). Nevertheless, differences in
task-related oxygen uptake between CHF patients and
healthy subjects remained after exclusion of CHF patients
with COPD. Finally, the current ﬁndings need to be
interpreted in the light of the number of comparisons/cor-
relations that were made in the present study (Perneger
1684 Eur J Appl Physiol (2011) 111:1679–1686
1231998). However, multiple ﬁndings in the same direction,
rather than a single ‘statistically signiﬁcant’ result, suggest
that these are not due to chance alone.
To conclude, patients with CHF experience a relative
metabolic requirement during the performance of self-
paced domestic ADLs that is not similar that seen in their
healthy peers. These ﬁndings may not be extraordinary, but
are novel and represent a necessary step in improving our
understanding of what troubles patients the most—not
being able to do the things that they could when they were
healthy. Building upon our current ﬁndings and carrying
out more detailed descriptive studies as well as interven-
tional studies including studying the effects of exercise-
based rehabilitation programs [using interval type of
training (Meyer et al. 1998)] and/or patient-tailored occu-
pation therapy [using energy-conservation techniques
(Velloso and Jardim 2006)] will certainly be worthwhile
endeavours and may get us to the heart of the matter.
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